Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 182Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Bausch Health, Canada Inc.

02 3Takeda Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

Azilsartan Medoxomil, Chlorthalidone

Brand Name : EDARBYCLOR

Patent Number : 2557538

Filing Date : 2005-02-23

Strength per Unit : 40 mg / 12.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-02-23

Date Granted : 2010-08-17

blank

02

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

Azilsartan Medoxomil, Chlorthalidone

Brand Name : EDARBYCLOR

Patent Number : 2557538

Filing Date : 2005-02-23

Strength per Unit : 80 mg / 12.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-02-23

Date Granted : 2010-08-17

blank

03

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

Azilsartan Medoxomil, Chlorthalidone

Brand Name : EDARBYCLOR

Patent Number : 2557538

Filing Date : 2005-02-23

Strength per Unit : 40 mg / 25 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-02-23

Date Granted : 2010-08-17

blank

04

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

Azilsartan Medoxomil, Chlorthalidone

Brand Name : EDARBYCLOR

Patent Number : 2125251

Filing Date : 1994-06-06

Strength per Unit : 40 mg / 12.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-06-06

Date Granted : 2005-04-26

blank

05

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

Azilsartan Medoxomil, Chlorthalidone

Brand Name : EDARBYCLOR

Patent Number : 2125251

Filing Date : 1994-06-06

Strength per Unit : 80 mg / 12.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-06-06

Date Granted : 2005-04-26

blank

06

arrow
Pharmaconex
Not Confirmed
arrow
Pharmaconex
Not Confirmed

Azilsartan Medoxomil, Chlorthalidone

Brand Name : EDARBYCLOR

Patent Number : 2125251

Filing Date : 1994-06-06

Strength per Unit : 40 mg / 25 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-06-06

Date Granted : 2005-04-26

blank

07

Bausch Health, Canada Inc.

arrow
Pharmaconex
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
Pharmaconex
Not Confirmed

Azilsartan Medoxomil, Chlorthalidone

Brand Name : EDARBYCLOR

Patent Number : 2732018

Filing Date : 2009-07-29

Strength per Unit : 40 mg / 12.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2029-07-29

Date Granted : 2017-07-04

blank

08

Bausch Health, Canada Inc.

arrow
Pharmaconex
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
Pharmaconex
Not Confirmed

Azilsartan Medoxomil, Chlorthalidone

Brand Name : EDARBYCLOR

Patent Number : 2681143

Filing Date : 2008-03-26

Strength per Unit : 40 mg / 12.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2028-03-26

Date Granted : 2017-01-03

blank

09

Bausch Health, Canada Inc.

arrow
Pharmaconex
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
Pharmaconex
Not Confirmed

Azilsartan Medoxomil, Chlorthalidone

Brand Name : EDARBYCLOR

Patent Number : 2732018

Filing Date : 2009-07-29

Strength per Unit : 80 mg / 12.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2029-07-29

Date Granted : 2017-07-04

blank

10

Bausch Health, Canada Inc.

arrow
Pharmaconex
Not Confirmed

Bausch Health, Canada Inc.

Country
arrow
Pharmaconex
Not Confirmed

Azilsartan Medoxomil, Chlorthalidone

Brand Name : EDARBYCLOR

Patent Number : 2681143

Filing Date : 2008-03-26

Strength per Unit : 80 mg / 12.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2028-03-26

Date Granted : 2017-01-03

blank